Letter by Dregelid regarding article, "impact of femoral vascular closure devices and antithrombotic therapy on access site bleeding in acute coronary syndromes: the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial".
Dregelid
Einar
E
D054058:Acute Coronary Syndrome / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology / Q000601:surgery*; D016063:Blood Loss, Surgical / Q000401:mortality / Q000517:prevention & control; D002408:Catheters, Indwelling / Q000009:adverse effects* / Q000706:statistics & numerical data; D005263:Femoral Artery / Q000601:surgery*; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D008026:Ligation / Q000295:instrumentation* / Q000379:methods; D011475:Prosthesis Failure; D016459:Prosthesis-Related Infections / Q000209:etiology; D016019:Survival Analysis
D005343:Fibrinolytic Agents